PFSA Stock Summary and Trading Ideas (Profusa | NASDAQ:PFSA)

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

What symbol and exchange does Profusa shares trade?

Profusa trades on the NASDAQ stock market under the symbol PFSA.

What is Profusa stock price doing today?

As of December 19, 2025, PFSA stock price climbed to $0.12 with 2,719,944 million shares trading.

What is Profusa's Beta?

PFSA has a beta of 3.66, meaning it tends to be more sensitive to market movements. PFSA has a correlation of 0.10 to the broad based SPY ETF.

How much is Profusa worth?

PFSA has a market cap of $7.72 million. This is considered a Sub-Micro Cap stock.

What are the top ETFs holding Profusa?

The top ETF exchange traded funds that PFSA belongs to (by Net Assets): VXF.

What are the support and resistance levels for Profusa (PFSA)?

PFSA support price is $.10 and resistance is $.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PFSA shares will trade within this expected range on the day.